-
DE
Fibrinolytic refers to the ability to dissolve blood clots. Fibrinolytic agents are used in medicine to treat serious conditions such as stroke, heart attack, and pulmonary embolism.
Fibrinolytic refers to the ability to dissolve blood clots. Fibrinolytic agents are used in medicine to treat serious conditions such as stroke, heart attack, and pulmonary embolism.
Fibrinolytic describes the ability of a substance or biological process to dissolve fibrin – the primary structural component of blood clots. The term combines the Latin word fibrin (the fibrous protein of blood) and the Greek word lysis (dissolution). Fibrinolytic processes play a central role in maintaining the natural balance between blood clotting and clot dissolution in the human body.
In the body, fibrinolysis is mediated by the enzyme plasmin. Plasmin is generated from its inactive precursor plasminogen when so-called plasminogen activators – such as the endogenous t-PA (tissue plasminogen activator) – convert it to its active form. Plasmin then cleaves the fibrin strands of a blood clot into smaller fragments known as fibrin degradation products, effectively dissolving the clot.
Fibrinolytic medications mimic or enhance this process by activating plasminogen, thereby accelerating the breakdown of pathological blood clots.
Fibrinolytic agents – also known as thrombolytics – are used in emergency medicine and clinical practice to treat life-threatening thrombotic conditions. Key indications include:
The most commonly used fibrinolytic medications include:
The greatest risk associated with fibrinolytic therapy is an increased risk of bleeding. Because the medication can dissolve both pathological and physiologically important clots, potential complications include:
As a result, the use of fibrinolytic agents is subject to strict contraindications, such as recent surgery, known history of brain hemorrhage, or uncontrolled hypertension.
Beyond pharmacological therapy, endogenous fibrinolysis is a critical mechanism for maintaining hemostasis – the balance between blood vessel patency and clot formation. A disruption in this balance – whether excessive or insufficient fibrinolysis – can lead to serious conditions, including thrombosis, embolism, or pathological bleeding tendencies.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.